Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Dividend Champion, Contender, And Challenger Highlights: Week Of October 15
11:18am, Saturday, 14'th Oct 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Quest Diagnostics (DGX) to Boost Lab Services With New Pact
12:47pm, Friday, 06'th Oct 2023
Quest Diagnostics (DGX) latest deal will boost dialysis laboratory testing and reduce the laboratory costs of dialysis programs for ESRD patients.
Quest Diagnostics to Release Third Quarter 2023 Financial Results on October 24, 2023
10:05am, Wednesday, 04'th Oct 2023
SECAUCUS, N.J. , Oct. 4, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2
Should Value Investors Buy Quest Diagnostics (DGX) Stock?
11:16am, Monday, 02'nd Oct 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
12:02pm, Wednesday, 20'th Sep 2023
Investors are optimistic about Quest Diagnostics (DGX), backed by collaborations with health plans and upbeat guidance.
Quest Diagnostics (DGX) to Aid Health Equity With New Pact
12:46pm, Thursday, 14'th Sep 2023
Quest Diagnostics (DGX) and Americares will provide 10 clinics with no-cost diagnostic services for a year to help patients manage chronic disease.
Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference
11:38am, Friday, 08'th Sep 2023
SECAUCUS, N.J. , Sept. 8, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Sam Samad, Executive Vice Pre
Quest Diagnostics' (DGX) AAV Test Gets FDA's Breakthrough Nod
09:02am, Friday, 01'st Sep 2023
Quest Diagnostics (DGX) achieves breakthrough designation for AAVrh74 ELISA and expands collaboration with Sarepta Therapeutics.
Why Is Quest Diagnostics (DGX) Down 0.9% Since Last Earnings Report?
12:48pm, Friday, 25'th Aug 2023
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
3 Pharma Stocks to Buy as Summer COVID Cases Spike
05:11am, Wednesday, 23'rd Aug 2023
Covid-19 related stocks started spiking again this week. Driven primarily by reports about new variants and increasing spread.
Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
02:37am, Tuesday, 15'th Aug 2023
Quest Diagnostics has a strong Q2 with a slight beat on EPS and revenue. Quest's base business appears to be recovering from the pandemic and pulled in $2.30B in revenue. Despite fading COVID-related
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
11:39am, Monday, 14'th Aug 2023
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and acquisitions.
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
09:53am, Wednesday, 09'th Aug 2023
Biogen and Eli Lilly both have treatments to help reduce cognitive decline in Alzheimer's patients. But the key to their effectiveness is in treating people who have the disease in its early stages.
Looking for a Bargain? 3 Stocks to Buy That Are Down 10% in 2023
06:00am, Wednesday, 02'nd Aug 2023
Walking into the latter half of 2023, we're looking at a very different stock market than a year ago. Despite elevated interest rates and ongoing inflation, the S&P 500 is up for the fifth consecutive
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer's disease
07:23am, Monday, 31'st Jul 2023
Quest Diagnostics Inc. DGX, +0.10% said Monday it has brought the first blood-based biomarker test to assess the risk of developing Alzheimer's disease to market and it's now available for consumer pu
